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CLINICAL STUDIES OF HEMOFILTRATION
一1一 SOLUTE REMOVABILITY
   Akio IMAGAwA， Toshiaki TAMAKi， Masataka
     YoNEzAwA and Morimasa KuwAHARA
From the Urological Clinic， Takamatsu Red Cross HlosPital， Kagawa， JlaPan
  Eight patients of renal insuMciency were treated by hemofiltration （HF） for about three monthsi，
and the re皿ovability of solute was investigated．
  In the ｝｛．［．F treatment， filtrat．ien of O．4 liters per unit body weight each was perforrned three times
a week according to the post－dilution method． As the substitution fluid， the modified lactated Ringer’s
solution （Midorijuji） was used．
  The趾ration of O．41iters provided suflicient removal of low molecular weight substancc， and
produced thcrapeutic effects similar to those of the conventional hemodialysis． The seru皿Pand
Ca dropped more significantly than in the hemodialysis method． Meanwhile， it was considered
necessary to increase the content of Ca in the substitution fiuid．
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C G N：Chron，ic gnomeluronephritis
Table 2． Compositions of substitution fluid
Na K ci Ca Mg lactateosmolarity

















































O－O HF n＝ ss
O－o HD n＝ 40
P〈O．01
37
Pre Post Pre Post
























 3） Ht， Hb
 HF（n－24）の開始時にはHt 19．55圭3．85％， Hb
6．35土1．37mg／d1で，終了時にはHt 22．05士5．64％．
Hb 7．25士1．68皿9／dlであった． HD（n＝28）の開
始時にはHt l8．84士4．38％， Hb 6．11土1．52 mg／d1
で，終了時にはHt 20．37±4．62％， Hb 6．59±i．66
mg／dlであった． HF， HDを比較するとHt， Hbと
Table 3． Changes of electrolyte （HF n＝38， HD n＝＝＝51）
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Table 4． Changes of blood chemistry （n＝8）

























 4）GOT， GPT，Al－P，総コレステロー・一ル， TP
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一訂 正一
P．38Table 4の「before HF」および「after 3 M」のおのおのの2つの値の
問にすべて「±二！が入ります．
